Peter Kim

Investor type:

Social media:

Available after registration.

Past investments

  • Precision NanoSystem
  • Vor Biopharma
  • Aprea
  • Arvinas
  • GenePeeks
  • RareCyte
  • Portal Instruments
  • Entrada Therapeutics
  • Ceterix Orthopaedics
  • Audentes Therapeutics
  • CinCor Pharma
  • Homology Medicines
  • Cabaletta Bio
  • Flexion Therapeutics
  • Expansion Therapeutics
  • Spyryx Biosciences
  • Ensoma
  • Cleave Therapeutics
  • Nohla Therapeutics
  • scPharmaceuticals
  • Wildcat Discovery Technologies
  • Scientist.com
  • Relypsa
  • Purigen Biosystems
  • Epirus Biopharmaceuticals
  • Rallybio
  • Pulmatrix
  • Crinetics Pharmaceuticals
  • NodThera
  • Kinaset Therapeutics
  • Calibrium
  • Inipharm
  • Kinestral Technologies
  • Magnetic Insight
  • TMRW Life Sciences
  • Pearl Therapeutics
  • Chrono Therapeutics
  • Impel NeuroPharma
  • Igenica
  • Nouscom
  • Novira Therapeutics
  • Bird Rock Bio
  • Viveve
  • Enliven Therapeutics
  • Millendo Therapeutics
  • Pear Therapeutics
  • Achaogen
  • Escient Pharmaceuticals
  • Artiva Biotherapeutics
  • Cidara Therapeutics
  • Akouos
  • Bellerophon Therapeutics
  • IDEAYA Biosciences
  • BlueLight Therapeutics
  • Neurogastrx
  • Novome Biotechnologies